Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib with Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NCT01828034Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2013
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib in biliary tract carcinoma (BTC), sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2013; status: completed.
02
Drugs
binimetinib
03
Conditions
biliary tract carcinoma (BTC)
Beyond the preview
Go deeper on NCT01828034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828034.